BASF is increasing its global production capacity for Neopor (expandable polystyrene containing graphite) by a total of 40,000 metric tons per year. Adjustments in the plants at the two production sites in Ludwigshafen, Germany, and Ulsan, Korea, will take place through the fourth quarter of 2018. The raw material is processed into insulation boards, which […]
Post Type Archives: News
Minakem opens new high containment facility for highest class of HPAPI
Minakem, the CDMO division of Minafin, specialized in custom development and manufacturing of building blocks, GMP intermediates and Active Pharmaceutical Ingredients (APIs and HPAPI), today announces it is in the final qualification run to open a new closed-controlled environment high containment production facility in August. This high-class production facility is among only a dozen of […]
BASF expands global insecticide portfolio
BASF has received the first global registrations in Australia and India for the new active ingredient, Inscalis insecticide (afidopyropen). The company anticipates further registrations in the US, Canada, Mexico, China, and Argentina. The active ingredient was discovered by the Japanese company Meiji Seika Pharma (Meiji) and the Kitasato Institute, specifically 2015 Nobel Prize recipient, Doctor […]
Biesterfeld to distribute Sandream pigments for European cosmetic markets
US-based effect pigment supplier Sandream Impact and Biesterfeld Spezialchemie have signed a distribution agreement for the European cosmetic markets. The specialty chemicals distributor now represents the US company in the German-speaking DACH region, Eastern Europe and Turkey. With more than 800 products, Sandream Impact’s portfolio is characterized by its very wide variety. Natural and synthetic […]
Seipasa doubles biopesticide production capacity with plant expansion in Spain
Seipasa, a company specialized in the formulation, development and marketing of botanical and microbiological-based solutions (biopesticides, biostimulants and fertilizers) for agriculture, has announced the expansion of its production plant in Valencia, Spain. The work involved a complete restructuring of Seipasa’s manufacturing, packaging and logistics centre. The facilities have been extended by 3,000m2 to double […]
Valagro launches water-soluble fertilizers in China
V alagro said it launched its water-soluble fertilizers, Master Supreme, to the Chinese market at the NCIC Global Specialty Fertilizer Convention. Master Supreme is a new solution created by Valagro, that is able to provide a guaranteed nutritional and biostimulant effect. Master Supreme water-soluble fertilizers line has a high quality and purity and is enriched […]
Azelis to change ownership by end 2018
Azelis, a leading global specialty chemicals and food ingredients distributor, today announced that Funds advised by Apax Partners, the global private equity advisory firm, have received a binding offer and have entered into exclusive discussions to sell Azelis to the EQT VIII fund and PSP Investments. The transaction, which is subject to regulatory approvals, and […]
Evonik launches new membrane for efficient natural gas processing
At this year’s ACHEMA in Frankfurt am Main (Germany), Evonik presented its latest membrane product development – SEPURAN NG for efficient natural gas processing – to an international trade audience. SEPURAN NG is an especially robust, hollow-fibre membrane, which is based on a high-performance plastic that can withstand extreme pressure and temperatures. This enables particularly selective separation […]
Ginkgo Bioworks marks 10 year anniversary with iGEM partnership
Today, Ginkgo Bioworks, the organism design company, announced its commitment as a lead partner of the 2018 International Genetically Engineered Machine, also known as iGEM. The 10th anniversary of Ginkgo’s founding offers a time to reflect on the company’s successes and an opportunity to invest in and foster the future of synthetic biology. Including one of […]
Sanofi and Translate Bio to develop mRNA vaccines in $805 million deal
Sanofi Pasteur, Sanofi’s vaccines global business unit, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, have formed a multi-year research and development (R&D) pact and licensing deal to develop mRNA vaccines for up to five undisclosed infectious disease pathogens in a deal worth up to $805 million. Under the agreement, Translate Bio and […]